Prices delayed by at least 15 minutes | Print
Verici Dx PLC (VRCI)
ORD GBP0.001Open
1.875p
Previous close
1.875p
Trade high
2.00p
Volume
1,060,557
Year high
8.693p
Year low
1.00p
Dividend yield
–
Market capitalisation
£4.24 mn
P/E ratio
–
ISIN
GB00BM8HZD43
This share can be held in a Dealing accountStocks and shares ISALifetime ISAJISASIPPand can be used with Dividend reinvestment
Share price
Company profile
Verici Dx PLC is an immuno-diagnostics development company. The company is focused on developing diagnostics technologies that will help understand the outcomes of an organ transplant surgery. There are two products for clinical validationand commercialization: Clarava, which is a pre-transplant prognosis for the risk of early acute rejection; and Tuteva, a post-transplant diagnostic focused upon acute cellular rejection including sub-clinical rejection not being diagnosed through the current standard of care of rising serum creatine levels. The business of the Group comprises a single activity, which of the development of prognostic and diagnostic tests for kidney transplant patients.
News
Recent trades
| Date | Time | Price | Quantity | Value (£) |
|---|---|---|---|---|
| 28/04/2025 | 04:10:59 | 1.5 | 38 | 0.57 |
| 28/04/2025 | 04:10:34 | 1.51 | 300,000 | 4,530.00 |
| 28/04/2025 | 04:04:04 | 1.58 | 4,421 | 69.85 |
| 28/04/2025 | 04:00:26 | 2 | 500 | 10.00 |
| 28/04/2025 | 04:00:26 | 2 | 470 | 9.40 |
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2025 AJ Bell. All rights reserved.